Esperion Therapeutics, Inc. (NASDAQ: ESPR)
$2.2900
-0.0100 ( +2.23% ) 2.0M
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Market Data
Open
$2.2900
Previous close
$2.3000
Volume
2.0M
Market cap
$453.18M
Day range
$2.1870 - $2.3050
52 week range
$1.5800 - $3.9400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Sep 18, 2024 |
4 | Insider transactions | 2 | Aug 20, 2024 |
8-k | 8K-related | 14 | Aug 12, 2024 |
10-q | Quarterly Reports | 72 | Aug 12, 2024 |
8-k | 8K-related | 14 | Aug 05, 2024 |
4 | Insider transactions | 2 | Jul 19, 2024 |
4 | Insider transactions | 2 | Jul 19, 2024 |
8-k | 8K-related | 14 | Jun 28, 2024 |
4 | Insider transactions | 2 | Jun 20, 2024 |
4 | Insider transactions | 2 | Jun 20, 2024 |